Article
A Mutational Signature that Predicts Prognosis and Benefit of Immune Checkpoint Blockade in Colorectal Cancer
2020-12-11
Abstract excerpt
<h4>Background: </h4> Colorectal cancer (CRC) is characterized by broad genomic and transcriptional heterogeneity. However, the genomic basis of this variability remains poorly understood. Our pilot study identified mutated genes were associated with immune infiltration. This study aims to explore a novel mutational signature (MS) in tumor microenvironment (TME) of CRC. <h4>Methods: </h4>: We integrated single nuc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fae9833d-1a73-5319-a210-5f4245e1c9e9
- DOI
- 10.21203/rs.3.rs-122186/v1
